Table 2.
Tumor type and histology | No. of patients | % |
---|---|---|
Uterine cancer | 116 | 64.1 |
Endometrioid | 87 | 75.0 |
Mixed | 8 | 6.9 |
Serous | 7 | 6.0 |
Othera | 4 | 3.4 |
Clear cell | 3 | 2.6 |
ESSb | 3 | 2.6 |
Carcinosarcoma | 2 | 1.7 |
Leiomyosarcoma | 2 | 1.7 |
| ||
Cervical cancer | 50 | 27.6 |
Squamous | 24 | 48.0 |
Adenocarcinoma | 18 | 36.0 |
Clear cell | 4 | 8.0 |
Adenosquamous | 2 | 4.0 |
Small cell | 1 | 2.0 |
Neuroendocrine | 1 | 2.0 |
| ||
Ovarian cancer | 11 | 6.1 |
Low malignant potential | 5 | 45.4 |
Mixed | 2 | 18.2 |
Sex cord stromal | 2 | 18.2 |
Endometrioid | 1 | 9.1 |
Mucinous | 1 | 9.1 |
| ||
Unknown primary | 2 | 1.1 |
| ||
Fallopian tube cancer | 1 | 0.6 |
Serous | 1 | 100 |
| ||
Otherc | 1 | 0.6 |
Other: uterine sarcoma, endometrioid adenosarcoma, undifferentiated adenocarcinoma of endometrium.
Endometrial stromal sarcoma
Gallbladder carcinoma metastasized to the ovary.